Pathstone Holdings’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,977
Closed -$359K 2306
2025
Q4
$359K Sell
7,977
-3,442
-30% -$159K ﹤0.01% 1882
2025
Q3
$510K Sell
11,419
-61
-0.5% -$2.92K ﹤0.01% 1761
2025
Q2
$552K Sell
11,480
-5,440
-32% -$237K ﹤0.01% 1677
2025
Q1
$679K Buy
16,920
+1,162
+7% +$48.9K ﹤0.01% 1567
2024
Q4
$722K Sell
15,758
-173
-1% -$7.75K ﹤0.01% 1539
2024
Q3
$747K Sell
15,931
-1,201
-7% -$54.8K ﹤0.01% 1518
2024
Q2
$724K Buy
17,132
+303
+2% +$13.3K ﹤0.01% 1496
2024
Q1
$745K Buy
+16,829
New +$767K ﹤0.01% 1475

Other funds holding QGEN

Pathstone Holdings's QGEN Position: Q1 2026 in Review

Pathstone Holdings sold out of Qiagen (QGEN) in Q1 2026, closing a stake of 7,977 shares — an estimated $359K sold.

Pathstone Holdings first reported a position in QGEN in Q1 2024 and held it in 8 quarters. The position peaked at $747K in Q3 2024. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.

  • Pathstone Holdings reported no remaining Qiagen position as of Q1 2026 after selling out during the quarter.
  • Pathstone Holdings sold 7,977 Qiagen shares in Q1 2026, an estimated $359K.
  • Pathstone Holdings first reported a position in Qiagen in Q1 2024 and held it in 8 quarters.
  • Pathstone Holdings's Qiagen position peaked at $747K in Q3 2024.
  • 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.